We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
LSE:0XOD
​
​
logo

UroGen Pharma Ltd. (0XOD)

LSE • 0XOD • IL0011407140

30.29Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 1.2% of free float is sold short, 919.4 days to cover, cost to borrow 0.43%.

Market Cap

1.4b USD | # 1982 in GB

Volume

1.23k shares | 41.6m USD

Shares Outstanding

48.88m

Free Float Shares

88.80% | 43.41m

Nasdaq:URGN|
DB:UR8

News

0XOD key data

UroGen Pharma Ltd. (LSE: 0XOD) has a market capitalization of $1.4B. Last close $30.29 (as of 2026-11-05); 52-week range $16.19 to $51.11. ORTEX data as of 2026-11-03: short interest is 1.22% of free float, 919.4 days to cover and the average cost to borrow is 0.43%.

  • 0XOD news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.